Krish Pharma Speciality Private Limited made an offer to acquire approximately 8.64% stake in Shreyas Intermediates Limited (BSE:526335) for INR 61.2 million on March 17, 2022. In related transaction, Krish Pharma Speciality Private Limited agreed to acquire 24.7% stake in Shreyas Intermediates Limited from Invent Assets Securitization and Reconstruction Private Limited for INR 175 million on March 17, 2022. The transaction is subject to approval of Reserve Bank of India (RBI) and no other statutory approvals required.

The offer will open on May 13, 2022, and close on May 27, 2022. As of June 27, 2022, The offer will open on June 28, 2022, and close on July 11, 2022. Fedex Securities Limited acted as manager to the offer and Link Intime India Pvt.

Ltd. acted as registrar to the offer.